Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study Group.

Human immunodeficiency virus type 1 (HIV-1) isolates resistant to zidovudine (ZDV) have previously been demonstrated to exhibit in vitro cross-resistance to other similar dideoxynucleoside agents which contain a 3'-azido group. However, cross-resistance to didanosine (ddI) or dideoxycytidine (d...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Mayers, D L, Japour, A J, Arduino, J M, Hammer, S M, Reichman, R, Wagner, K F, Chung, R, Lane, J, Crumpacker, C S, McLeod, G X
Format: Artigo
Jezik:Inglês
Izdano: 1994
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC284445/
https://ncbi.nlm.nih.gov/pubmed/8192457
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki